Portuguese Institute of Oncology (IPO-Porto)

Porto, Portugal

Congratulations to Dr. Belarmino Gonçalves, Mr. Manuel Freitas, and the interventional oncology team at Portuguese Institute of Oncology (IPO-Porto) on achieving IASIOS accreditation.

This important milestone reflects a collective commitment to excellence in interventional oncology and to delivering care in line with internationally recognised quality standards. Through the successful implementation of the CIRSE Standards of Quality Assurance, the team has demonstrated its dedication to clinical excellence, multidisciplinary collaboration, and continuous quality improvement.

IASIOS accreditation recognises the team’s commitment to providing safe, effective, and patient-focused image-guided cancer therapies, while further strengthening quality assurance across their service.

We are delighted to celebrate this outstanding achievement and extend our sincere congratulations to Dr. Gonçalves, Mr. Freitas, and the entire team at IPO-Porto on this well-deserved success.